Radian B is relevant for easing symptoms related to physical discomfort in the musculoskeletal system, offering supportive comfort in situations marked by heightened physiological activity or temporary strain. The product is used for the temporary relief of aches and pains of muscles and joints associated with conditions like simple backache, lumbago, strains, and sprains.

The product is applied across therapeutic domains where short-term symptomatic assistance is needed. It is commonly used to help with acute muscle soreness and rigidity, minor soft tissue injuries, and recurrent rheumatic discomforts. The overall benefit is that it contributes to easing the overall symptom load and supports patients during episodes of heightened discomfort that interfere with daily functioning.

Quick Fact: Relief for Musculoskeletal Discomfort

Radian B may be part of symptomatic management when dealing with conditions characterized by periods of heightened symptoms, such as the pain associated with strains, stiffness, and chronic lumbago. It may assist with managing symptoms that create noticeable physiological strain and interfere with daily functioning.

Regulatory References

1. Natural health product licence amendment and notification form

Eligibility Map: Who can and cannot use Radian B Ibuprofen 5% w/w Gel

This profile is based on official regulatory documentation and details specific population eligibility and prohibition rules.

---

Category	Official Regulatory Statement
Populations for whom use is allowed	Adults, the elderly, and adolescents 12 years of age and over [SmPC, HPRA].
Populations for whom use is contraindicated	Patients with known hypersensitivity to ibuprofen, aspirin, other NSAIDs, or any product excipient [SmPC, HPRA].
Age-related eligibility rules	Contraindicated in children under 12 years of age. No special dose adjustment is necessary for the elderly [SmPC, HPRA].
Pregnancy eligibility status	Contraindicated in the third trimester of pregnancy [SmPC, HPRA]. Not recommended in the first and second trimesters unless clearly necessary [PIL, MHRA].
Condition-specific rules	Must not be used on broken, damaged, or infected skin. Caution is required in patients with impaired renal function or a history of peptic ulcer [SmPC, HPRA].

---

Official eligibility statements:

• Use is contraindicated in children under 12 years, in the third trimester of pregnancy, and in individuals with a history of allergic reactions (including asthma) to ibuprofen, aspirin, or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
• The medicine is appropriate for adults and adolescents 12 years and over, but requires caution if the patient has a history of gastrointestinal issues or impaired renal function.

Connection to the overall eligibility profile

Regulatory documents establish absolute non-eligibility through contraindications based on age, allergy history, and advanced pregnancy status. The labeling mandates that all use outside of the approved populations and those with specific comorbidities requires medical consultation or is strictly prohibited, thereby defining the official boundaries of use.

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of topical Ibuprofen primarily around pharmacodynamic effects, which arise despite the product's low systemic absorption. The official profile mandates specific restrictions and cautions related to co-administered systemic medicines.

Documented Drug-Drug Interactions

Classification	Interacting Substance/Class	Documented Interaction Outcome
Contraindicated	Oral NSAIDs / Aspirin	Increased incidence of adverse reactions when co-administered.
Pharmacodynamic	Anticoagulants (e.g., Warfarin)	Potential for enhanced effects, increasing bleeding risk.
Pharmacodynamic	Low-Dose Aspirin	May inhibit the antiplatelet effect of low-dose Aspirin.
Pharmacodynamic	Antihypertensives / Diuretics	Potential for reduction in effectiveness of blood pressure-lowering drugs.

Interaction-Related Restrictions and Cautions

Co-administration with other oral NSAIDs or Aspirin (Acetylsalicylic Acid) is prohibited as a formal restriction. Additionally, the regulatory label requires that co-application with other topical products on the same area should be avoided. The product must not be used with occlusive dressings.

Specific caution is advised regarding interaction relevance in certain populations. Patients with existing impaired renal function require caution, especially when co-administering with Diuretics or ACE Inhibitors, due to the potential for rare systemic complications. Similarly, caution is noted for patients with impaired hepatic function.

The pharmacological action of Radian B Ibuprofen Gel is primarily defined by the molecular mechanism of its active ingredient, Ibuprofen, following its absorption into localized tissues. The mechanism involves the molecular modulation of pathways central to local inflammatory responses and nociception.

The core mechanism is the non-selective competitive inhibition of Cyclooxygenase (COX) enzymes. Ibuprofen acts directly upon both the constitutive COX-1 and inducible COX-2 isoforms, blocking the synthesis of Prostaglandins. This suppression of the Arachidonic Acid Cascade is the primary event that shapes the drug’s physiological effects.

The suppression of Prostaglandin production leads directly to a desensitization of peripheral nociceptors (pain-sensing nerve endings). Furthermore, the mechanism modulates the inflammatory process by limiting the Prostaglandin-driven vasodilation and increased capillary permeability at the injury site. This sequential cascade results in reduction of nociceptor signal generation and suppression of the vascular changes that allow fluid extravasation (oedema formation).

This mechanism is physiologically constrained by its localized application, making the resulting degree of COX inhibition directly dependent on the concentration gradient of Ibuprofen achieved in the underlying tissue.

Official Dosing and Frequency

The administration of Radian B Ibuprofen 5% w/w Gel is based on a localized protocol, emphasizing the topical route for external application to the skin only. The dosing regimen is standardized for adults, the elderly, and children aged 14 years and over. The standard single dose involves squeezing a strip of gel measuring approximately 5 to 10 cm (equivalent to 50 mg to 100 mg of Ibuprofen) from the tube and applying it to the area of discomfort. The frequency of application is defined by standardized use: a dose may be repeated every four hours as required, but the total number of applications must not exceed four times in any 24-hour period. For children under 14 years of age, the gel should not be used except under the specific advice of a doctor.

Procedural and Contextual Instructions

Application requires massaging the gel gently into the skin until it is fully absorbed. Following administration, hands must be washed immediately, unless the hands themselves are the area being treated. Proper use involves specific contextual constraints: the gel must not be applied under occlusive (airtight) dressings or plasters, and contact with broken skin or mucous membranes should be avoided. The medicine is intended for short-term symptomatic management, and it is recommended to seek professional medical advice if symptoms persist or do not improve after two weeks of use. This structured protocol outlines the process for the administration of the topical NSAID.

Research Evidence / Overview of Studies for Radian B

The evidence for topical ibuprofen, the active ingredient in Radian B, is derived from formal clinical research, primarily focusing on its study for localized musculoskeletal discomfort. This overview describes the research structures, the types of patient experiences observed, and the areas where data remains limited, based on reviews from authoritative scientific sources.

---

Evidence for Use in Acute Soft Tissue Injuries

The evidence base for acute injuries, such as recent sprains, muscle strains, or contusions, has primarily been evaluated in Randomized Controlled Trials (RCTs) and systematic reviews. These short-term trials were used in research exploring how symptoms change over time, comparing topical ibuprofen 5% gel against a non-active carrier gel (placebo) or against oral pain medication. The research examined outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level, typically over a period of about seven to fourteen days.

Findings describe patterns observed in the studies where patient-reported outcomes describing perceived discomfort were observed. Research describes how changes in pain intensity changed in the observed populations during the short duration of the study period. Research examined how systemic absorption varied, with data showing patterns related to the degree of systemic absorption when evaluated against the levels observed in studies with oral administration.

What remains uncertain for acute injuries is primarily related to long-term outcomes, as the injuries themselves are typically self-limiting. Follow-up durations were limited, and subgroup findings are uncertain for certain groups, such as older adults with complex health backgrounds, as the study populations often consisted of younger, relatively healthy individuals.

---

Evidence for Use in Chronic Musculoskeletal Discomfort

Topical ibuprofen was studied for conditions characterized by fluctuating or episodic manifestations, most notably osteoarthritis, a condition associated with chronic joint discomfort. Studies focused on episodes where symptoms become more noticeable, including outcomes related to functional limitations and pain intensity on movement. Studies report how symptoms changed in the observed populations over periods generally ranging from six to twelve weeks. The research is ongoing, and the findings were mixed regarding the contribution of the active ingredient in contrast to the topical carrier (the gel base itself). Data for certain groups remain insufficient, especially for chronic conditions other than osteoarthritis.

Common questions about Radian B (FAQ)

Q: How does the action of the rub/cream differ from the action of the ibuprofen gel?

The Radian B Ibuprofen Gel is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and works by blocking substances that cause inflammation. The Muscle Rub/Cream, which contains ingredients like menthol and camphor, is classified as a counter-irritant.

This counter-irritant action works differently, providing relief by creating a cooling or warming sensation on the skin.

---

Q: Is Radian B safe to use on skin that is bruised but not broken?

Official documents state that the product must not be applied to broken, damaged, or infected skin or open wounds. While bruised skin is not explicitly listed as damaged, the general regulatory principle is to avoid application where skin integrity is compromised (e.g., if the skin is cut or torn). The official documents emphasize that the application site must be intact.

---

Q: Does Radian B contain aspirin or any form of salicylate?

The Ibuprofen Gel formulation does not contain salicylates. However, the Muscle Rub, Lotion, and Spray formulations contain active ingredients such as Methyl Salicylate, which is a form of salicylate. This distinction is important for individuals with a known salicylate or aspirin allergy.

---

Q: Is it safe to use Radian B while I am pregnant or breastfeeding?

Regulatory documents state the Ibuprofen Gel is contraindicated in the third trimester of pregnancy. The Rub/Lotion/Spray formulations are also generally not recommended during pregnancy or lactation. The full details on eligibility are provided in the 'Who can and cannot use' section.

---

Q: Is a burning sensation or redness at the application site a normal or common side effect?

A mild burning sensation or local irritation can sometimes be experienced at the application site, which is described as a local skin reaction. For the Muscle Rub, specific non-active ingredients are officially noted as potentially causing stinging, burning, or local skin reactions. Official guidance indicates that if irritation persists or becomes concerning, the product's use is typically discontinued.

---

Q: What are the most commonly reported mild side effects of the topical application?

The most commonly reported mild effects are generally local skin reactions, such as a mild rash, itching, or irritation at the application site. These effects are usually temporary. If irritation persists or becomes concerning, official guidance suggests discontinuing the product.

---

Q: Can Radian B be used on large areas of the body without risk of systemic side effects?

Official guidance describes that the product should be used on the smallest area of skin necessary to treat the discomfort. Applying salicylate-containing products to large areas or for prolonged periods has been reported in regulatory documents to potentially lead to symptoms of systemic poisoning due to increased absorption.

---

Q: What should I do if Radian B accidentally comes into contact with my eyes or mucous membranes?

Regulatory information indicates that if the gel or rub accidentally contacts the eyes or mucous membranes, the affected area is typically rinsed immediately and thoroughly with plenty of water. If irritation continues after rinsing, official information suggests seeking medical guidance.

---

Q: Are there different strengths or concentrations available for the Radian B products?

Radian B is available in different product types. The Ibuprofen Gel is standardized at 5% w/w of the active ingredient. Other products, like the Muscle Rub/Spray, contain a mixture of different active ingredients, such as Menthol and Camphor, each at its own specific concentration.

---

Q: Can Radian B be used for simple bruising without underlying muscle pain?

The official therapeutic indications for the Muscle Rub/Cream formulations explicitly include the symptomatic relief of bruising. The Ibuprofen Gel is also generally indicated for localized pain and inflammation, which is often a component of bruising.

---

Q: What are the active ingredients in the Radian B Muscle Rub formulation?

The active ingredients listed in regulatory documents for the Muscle Rub/Cream formulation are menthol, camphor, methyl salicylate, and capsicum oleoresin (or capsaicin). These compounds work together to provide pain relief.

---

Q: How long does it usually take for Radian B to start providing noticeable relief?

Studies examining topical ibuprofen gel, the active ingredient in one formulation, have indicated a median time to significant pain relief was observed to be around 25 minutes. This data provides an indication of how quickly the active ingredient may begin its localized effect.

---

Q: What is the specific role of Menthol and Camphor as active ingredients?

Official descriptions state that Menthol relieves itching and produces a sensation of coldness followed by an analgesic effect. Camphor acts as a rubefacient (causing temporary redness) and a mild analgesic.

Both are considered counter-irritants, drawing attention away from the deeper underlying pain.

---

Q: Is the strong odor of the rub/cream a sign of its effectiveness?

Official documents describe the Ibuprofen Gel as being odourless. The strong scent associated with the Muscle Rub/Cream is due to the presence of ingredients like menthol and camphor, which are naturally aromatic compounds known for their properties as counter-irritants.

Regulatory information does not explicitly draw a direct link between the strength of the odor and the product's effectiveness.

---

Q: What makes Radian B classified as a counter-irritant?

The Muscle Rub/Lotion/Spray formulations are classified as containing counter-irritants. This classification is based on their mechanism, which involves producing a localized sensation of heat or cold on the skin to help relieve the feeling of pain in the underlying muscle or joint.

---

Q: Is there a concern about using the spray version in confined spaces?

Official warnings indicate that the spray should not be used in confined spaces and that users should avoid inhaling the spray. The product also carries a fire hazard warning due to its highly flammable nature.

---

Q: Are there any specific warnings for people with diabetes or circulatory issues?

While diabetes is not explicitly listed as a contraindication, caution is generally advised for any patient with underlying circulatory issues. Warnings exist related to the systemic absorption of active ingredients which could affect patients taking blood thinners or blood pressure medicines.

---

Q: What is the official procedure for reporting a suspected side effect from Radian B?

Regulatory documents stress that reporting suspected adverse reactions is important for monitoring the safety of medicines. The official process involves reporting any suspected side effects to the relevant national regulatory body or Ministry of Health using the prescribed online or physical form.

---

Q: Does Radian B contain any ingredients that may trigger a known skin contact allergy?

Yes. Official documents list excipients such as cetostearyl alcohol, lanolin, and sodium laurilsulfate as components that may cause local skin reactions or contact dermatitis in sensitive individuals.

Fragrance ingredients in the formulation are also noted as potential allergens.

How to Store and Dispose of Radian B

The storage and disposal of Radian B Ibuprofen 5% w/w Gel must adhere strictly to official regulatory guidelines to maintain product quality and ensure safety.

Mandatory Storage and Handling

Requirement	Constraint
Temperature	Store below 25 C.
Child Safety	Keep out of the sight and reach of children.
Container Integrity	Replace the cap tightly after each use.
Fire Hazard Warning	Do not smoke or go near naked flames when handling the gel, as contact with fabrics may create a serious fire hazard.

Official Disposal Instructions

Unused or expired medicine must not be disposed of in waste-water or with household waste. For proper disposal, patients are instructed to ask a pharmacist how to discard medicines that are no longer required. The product must not be used past the expiration date printed on the packaging.